BTN1A1/Butyrophilin hFc Chimera, Human
BTN1A1/Butyrophilin HFc Chimera, Human

The purity of BTN1A1/Butyrophilin hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

BTN1A1/Butyrophilin HFc Chimera, Human

BTN1A1/Butyrophilin hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

BTN1A1/Butyrophilin hFc Chimera, Human

Butyrophilin 1A1 (BTN1A1) is one of the membrane proteins that surrounds LD,BTN1A1 plays an important role in regulating LD synthesis via a mechanism involving membrane phospholipid composition.
Z05090
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
BTN1A1/Butyrophilin (Ala27-Arg242)
Accession # Q13410		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 50.7 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • BTN1A1/Butyrophilin HFc Chimera, Human
    • BTN1A1/Butyrophilin HFc Chimera, Human

    The purity of BTN1A1/Butyrophilin hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • BTN1A1/Butyrophilin HFc Chimera, Human
    • BTN1A1/Butyrophilin HFc Chimera, Human

    BTN1A1/Butyrophilin hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Butyrophilin 1A1 (BTN1A1) is one of the membrane proteins that surrounds LD,BTN1A1 plays an important role in regulating LD synthesis via a mechanism involving membrane phospholipid composition.
Synonyms BT; BTN1A1; BTN; Butyrophilin

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.